Cargando…
A flexible mixed‐data model applied to claims data for post‐market surveillance of prescription drug safety behavior
We develop a new modeling framework for jointly modeling first prescription times and the presence of risk‐mitigating behavior for prescription drugs using real‐world data. We are interested in active surveillance of clinical quality improvement programs, especially for drugs which enter the market...
Autores principales: | Butler, Harris, Rice, John D., Carlson, Nichole E., Morrato, Elaine H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546139/ https://www.ncbi.nlm.nih.gov/pubmed/35373459 http://dx.doi.org/10.1002/pst.2213 |
Ejemplares similares
-
Empirical evaluation of the implementation of the EMA guideline on missing data in confirmatory clinical trials: Specification of mixed models for longitudinal data in study protocols
por: Häckl, Sebastian, et al.
Publicado: (2019) -
Why are two mistakes not worse than one? A proposal for controlling the expected number of false claims
por: Jaki, Thomas, et al.
Publicado: (2016) -
Data-driven treatment selection for seamless phase II/III trials incorporating early-outcome data
por: Kunz, Cornelia Ursula, et al.
Publicado: (2014) -
Temporary agency work, migration and the crisis in Greece: labour market segmentation intensified
por: Maroukis, Thanos
Publicado: (2016) -
Reference‐based sensitivity analysis for time‐to‐event data
por: Atkinson, Andrew, et al.
Publicado: (2019)